Tempest Therapeutics prices $2.5 million private placement at $0.81 per share

PUBT · 2d ago
Tempest Therapeutics prices $2.5 million private placement at $0.81 per share
  • Tempest Therapeutics priced a private placement of 3,105,591 common shares or pre-funded warrants at USD 0.81 with Series C and Series D warrants.
  • Gross proceeds expected at about USD 2.5 million; warrant exercises could add about USD 5 million, with no assurance of exercise.
  • Warrants carry a USD 0.81 exercise price; exercisable upon stockholder approval; Series C expires six years, Series D three years.
  • Closing expected on or about Sept. 14, 2026; H.C. Wainwright is exclusive placement agent.
  • Proceeds earmarked for working capital, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609110800PRIMZONEFULLFEED9825108) on September 11, 2026, and is solely responsible for the information contained therein.